Cargando…
Surrogate endpoints and competing risk of death in cardiac arrest research
We urgently need new therapies to improve outcomes after cardiac arrest. Initial studies typically target surrogate endpoints, and these studies help to inform subsequent larger trials that are powered to measure more patient-orientated clinical outcomes such as survival. The competing risk of death...
Autores principales: | McCredie, Victoria A., Scales, Damon C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926290/ https://www.ncbi.nlm.nih.gov/pubmed/27353499 http://dx.doi.org/10.1186/s13054-016-1345-y |
Ejemplares similares
-
The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project
por: Sargent, Daniel J., et al.
Publicado: (2017) -
Is critical care ready for an economic surrogate endpoint?
por: Wilcox, M Elizabeth, et al.
Publicado: (2015) -
Need for better reporting of trials with surrogate endpoints: SPIRIT|CONSORT-SURROGATE extensions
por: Ciani, Oriana, et al.
Publicado: (2022) -
Surrogate endpoints in trials: a call for better reporting
por: Ciani, Oriana, et al.
Publicado: (2022) -
How do we identify the crashing traumatic brain injury patient – the intensivist's view
por: McCredie, Victoria A., et al.
Publicado: (2021)